Electrophysiologic characteristics andimplications of induced ventricular fibrillationin symptomatic patients with brugada syndrome
Munetake Kanda, MD*,
Wataru Shimizu, MD, PhD*,*,
Kiyotaka Matsuo, MD*,
Noritoshi Nagaya, MD, PhD*,
Atsushi Taguchi, MD*,
Kazuhiro Suyama, MD, PhD*,
Takashi Kurita, MD, PhD*,
Naohiko Aihara, MD* and
Shiro Kamakura, MD, PhD*
* Division of Cardiology, Department of Internal Medicine, National Cardiovascular Center, Suita, Osaka, Japan
View larger version (15K):
[in a new window]
|
Figure 1 Kaplan-Meier curves of recurrent cardiac events (sudden cardiac death and ventricular fibrillation [VF] documented by an implantable cardioverter-defibrillator) in 22 patients with programmed ventricular stimulation (PVS)-induced VF (solid line) and in 12 patients without PVS-induced VF (dotted line).
|
|
|
